Treatment of patients with castration-resistant metastatic prostate cancer with nuclear medicine procedure

Phase 2

Recruiting

• Conditions: Malignant neoplasm of prostate; Castration resistant metastatic prostate cancer.

• Registration Number: IRCT20180113038331N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 20

Inclusion Criteria

Patients with Hx of metastatic prostate cancer resistant to usual treatment
Positive Ga68-PSMA PET/CT scan
ESOG 0-2

Exclusion Criteria

survival less than 4 months
GFR less than 40cc/min
?Serum creatinin >1.5
Urinary tract obstruction
Bone marrow suppression (WBC <2500 Plat<80000 Hct<8

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1-Change the number of metastases. Timepoint: After three cycle of therapy. Method of measurement: 1-Comparison with result of first functional and anatomical imaging.

Secondary Outcome Measures

Name	Time	Method
Intensity of pain. Timepoint: Before treatment and then every week until to the end of treatment. Method of measurement: Standard check list.;Quality of life. Timepoint: Every 15 days. Method of measurement: Karnofsky score.